Human pluripotent stem cell (hPSC)-induced NK (iNK) cells are a source of off-the-shelf cell products for universal immune therapy. Conventional methods for iNK cell regeneration from hPSCs include embryoid body (EB) formation and feeder-based expansion steps, which are time-consuming and cause instability and high costs of manufacturing. Here, we develop an EB-free, organoid aggregate method for NK cell regeneration from hPSCs. In a short time-window of 27-day induction, millions of hPSC input can output over billions of iNK cells without the necessity of NK cell expansion feeders. The iNK cells highly express classical toxic granule proteins, apoptosis-inducing ligands, as well as abundant activating and inhibitory receptors. Functionally, the iNK cells eradicate human tumor cells via mechanisms of direct cytotoxicity, apoptosis, and antibody-dependent cellular cytotoxicity. This study provides a reliable scale-up method for regenerating human NK cells from hPSCs, which promotes the universal availability of NK cell products for immune therapy.
文章引用产品列表
-
- GAS005
- 固定破膜剂
Fix & Perm Kit固定破膜剂
- ¥640.00 – ¥10,010.00
-
- CS1001
- 刺激阻断剂
PMA/Ionomycin Mixture(250X)佛波酯/离子霉素混合物
- ¥460.00 – ¥2,060.00
-
- CS1002
- 刺激阻断剂
BFA/Monensin Mixture(250X) 布雷非德菌素A/莫能霉素混合物
- ¥460.00 – ¥2,060.00